ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.16
-0.15%
Bitcoin
67,262.08
-1.31%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cartesian Therapeutics Inc (RNAC) Quote

Cartesian Therapeutics Inc

Cartesian Therapeutics Inc (RNAC)

NASDAQ
16.16
-0.53
(-3.18%)
Closed July 22 4:00PM
Delayed by 15 minutes
16.15
-0.01
(-0.06%)
After Hours: 7:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
16.16
Bid
16.15
Ask
21.00
Volume
91,068
16.06 Day's Range 17.40
11.665 52 Week Range 42.60
Market Cap
297.016M
Previous Close
16.69
Open
17.32
Last Trade
1
@
16.85
Last Trade Time
Financial Volume
$ 1,509,993
VWAP
16.5809
Average Volume (3m)
157,005
Shares Outstanding
17,796,053
Dividend Yield
-
PE Ratio
-1.31
Earnings Per Share (EPS)
-12.35
Revenue
26M
Net Profit
-219.71M

About Cartesian Therapeutics Inc

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.selectabio.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAC. The last closing price for Cartesian Therapeutics was $16.69. Over the last year, Cartesian Therapeutics shares have traded in a share price range of $ 11.665 to $ 42.60.

Cartesian Therapeutics currently has 17,796,053 shares outstanding. The market capitalization of Cartesian Therapeutics is $297.02 million. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -1.31.

RNAC Latest News

More News

Cartesian Therapeutics Announces New Employment Inducement Grants

GAITHERSBURG, Md., July 08, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the...

July 08 2024
GlobeNewswire Inc.

Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

July 02 2024
GlobeNewswire Inc.

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

July 02 2024
GlobeNewswire Inc.

Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis

Trial met primary endpoint with statistical significance, with 71% of myasthenia gravis patients treated with Descartes-08 observed to have a clinically meaningful improvement in MGC score at...

July 02 2024
GlobeNewswire Inc.

Cartesian Therapeutics Announces New Employment Inducement Grant

GAITHERSBURG, Md., June 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the...

June 06 2024
GlobeNewswire Inc.

Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis

GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

May 22 2024
GlobeNewswire Inc.

Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

GAITHERSBURG, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune...

May 13 2024
GlobeNewswire Inc.

Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Topline data from Phase 2b trial of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy, in myasthenia gravis on track for mid-2024 On track to dose first patient in Phase...

May 08 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.54-8.7005649717517.720.9916.0615280117.56206098CS
4-6.78-29.555361813422.9429.6515.3128545918.67389763CS
12-4.74-22.679425837320.941.8715.3115700521.90997358CS
26-6.727-29.392231397722.88741.8711.66536064920.16562646CS
52-8.035-33.209340772924.19542.611.66554694723.27849563CS
156-8.035-33.209340772924.19542.611.66554694723.27849563CS
260-8.035-33.209340772924.19542.611.66554694723.27849563CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
AUGXAugmedix Inc
$ 2.27
(147.71%)
24.14M
XCURExicure Inc
$ 0.5351
(76.02%)
14.02M
PSNLPersonalis Inc
$ 3.83
(56.33%)
22.8M
MDBHMDB Capital Holdings LLC
$ 10.675
(37.21%)
126.45k
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M
HYZNHyzon Motors Inc
$ 0.149
(-47.54%)
23.63M
MEDSTRxADE Health Inc
$ 14.92
(-33.45%)
223.27k
SILOSilo Pharma Inc
$ 2.50
(-27.95%)
11.93M
KITTNauticus Robotics Inc
$ 0.0935
(-27.46%)
28.43M
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2602
(5.77%)
226.82M
NVDANVIDIA Corporation
$ 117.93
(-2.61%)
217.11M
SQQQProShares UltraPro Short QQQ
$ 8.46
(2.79%)
188.2M
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M

Discussion

View Full Feed
Squirrely_McShitty Squirrely_McShitty 5 minutes ago
60% - 40% positive.
CNNA
MrMyers MrMyers 6 minutes ago
Thank you canthelpit. The only silver lining is being able to follow .0000 trades with .0001 bids that are filled below .0001. Doesn’t happen very often.
GTCH
MrMyers MrMyers 10 minutes ago
$GTB TECH posted on LinkedIn this afternoon. The post addresses 1) the immense importance of cybersecurity, 2) and the company’s expertise in the field of cybersecurity to provide solutions. GBT TECH does indeed have cybersecurity intellectual property. My hope and prayer is that GBT TECH will ass
GTB
gimmee greenbacks gimmee greenbacks 11 minutes ago
10,000 new reads in the last two hours
to over 222,000 reads on Most Read Boards..




BIEL
BIEL
DD_dempsey DD_dempsey 13 minutes ago
Intriguing updates for $HIRU - patiently holding

I have held this stock now for 7 years and clearly - if this ends up being the reason why … a few ownerships and managements later - than so be it.

I can’t deny the last three sessions here as I went from Red to Green a
HIRU
236T568 236T568 15 minutes ago
The Anti-Trump

https://x.com/harryjsisson/status/1815095062512230855
236T568 236T568 18 minutes ago
There you go

https://x.com/MaryLTrump/status/1815136551984402819
sylvia07 sylvia07 19 minutes ago
How uplisting to a major exchange works and requirements...........
https://foundershield.com/blog/how-uplisting-stocks-works/
GRST
littlejohn littlejohn 23 minutes ago
call me nuts, SMCI to 1,200 this week

could be possible...

it could need some money rolling off

TSLA on Wednesday over to SMCI

to have a chance...

another article on new Nasdaq 100 entry...

https://finance.yaho
SMCI TSLA
Hanibal Hanibal 27 minutes ago
Lol. GOP in disarray. Let it all out big fella.

Not sure how you typed this out with a straight face considering it's Trump's MO

Elitist at their best, me,me, me, and me. No one else in the Country exists,
sylvia07 sylvia07 29 minutes ago
Sad but true!
GRST
kabunushi kabunushi 34 minutes ago
In any case imo the dude is off his rocker now, obsessively hating on people on this MB. Not at all the sign of a healthy individual dealing with whatever may have happened and moving on with his/her life as I would expect any normal person to. Whatever happened or didn't happen to him he's stuck in
NWBO
Louinjaxxx Louinjaxxx 35 minutes ago
Technically always has been Pink Current Information....just a matter of syncing report filings. Only nervous nancies and bashers are concerned.
AXXA
sage4 sage4 37 minutes ago
That makes total sense. A good strategic plan.
AVXL
sctts sctts 37 minutes ago
$$$ Today is the Day $$$$

$$$$ $frx $$$$
FRX
sage4 sage4 41 minutes ago
Now you are talking
AVXL
flipper44 flipper44 57 minutes ago
I played your post backwards and finally understood it.

Sprechen sie geek?
NWBO
nowwhat2 nowwhat2 58 minutes ago
Nite nite

https://investorshub.advfn.com/uimage/uploads/2024/7/22/uhombBTC_777_21_6M_11PM_OHTL_RESIST_2021.jpg



https://investorshub.advfn.com/uimage/uploads/2024/7/21/vromubtc_777_21_45d_8pm_w_666_10_1245_eth_etf.jpg



BTCUSD
Peeteman Peeteman 60 minutes ago
Pink Current now from what I see?
AXXA
littlejohn littlejohn 1 hour ago
China central bank cuts rates by 10

basis points today,

after Biden dropped out of race and

endorsed bad Karma...


Two items may not be related other than

timing to get ahead of potential fall out of

U
KILLAZILLA KILLAZILLA 1 hour ago
WRONG!!!
https://www.wsj.com/video/kamala-harris-calls-out-joe-biden-over-racial-issues/DAA0D8FE-AF38-47A0-A8F6-E1B6E04B2BFC
Real McCoy Real McCoy 1 hour ago
If it was actually confidential, no one including you would know.
VeronicaFox VeronicaFox 1 hour ago
Past ”Shortcomings”??? lol, that’s like saying a 100 mile hike is just a little jog. Scozzafava has destroyed numerous companies and left those shareholders in financial ruin. He has one of the highest R/S rates in the OTC, and has diluted every company he ran - this one is sitting in trips. Here
ALRN
Bob Mullet Bob Mullet 1 hour ago
To da mooooooonn!!!!

SOON??!?
KBLB

Your Recent History

NASDAQ
RNAC
Cartesian Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved